Affordable Generics And Digital Trends Will Broaden Global Healthcare Reach

Published
10 Feb 25
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
₹1,078.50
19.7% undervalued intrinsic discount
14 Aug
₹865.50
Loading
1Y
-33.6%
7D
-3.3%

Author's Valuation

₹1.1k

19.7% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Decreased 26%

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Increased 7.21%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Decreased 0.47%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Increased 35%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on13 Mar 25